BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Post-LOE

brimonidine tartrate; timolol maleate

Sentiss
ANDAOPHTHALMICSOLUTION/DROPS
Approved
Oct 2022
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

tartrate/timolol maleate ophthalmic solution is comprised of two components: brimonidine tartrate and timolol. Each of these two components decreases elevated intraocular pressure, whether or not associated with glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of…

Indications (5)

elevated intraocular pressure (IOP) in patients with glaucomaocular hypertensionreplacement therapy due to inadequately controlled IOPhypertensionglaucoma
Company
Sentiss
Sentiss
India - Gurugram
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers